Indicators
Indicators
Value
Direction
MACD(12,26,9)
-1.296
Sell
RSI(14)
49.394
Neutral
STOCH(KDJ)(9,3,3)
39.184
Buy
ATR(14)
6.093
Low Volatility
CCI(14)
-6.649
Neutral
Williams %R
64.262
Sell
TRIX(12,20)
-0.210
Sell
StochRSI(14)
100.000
Buy
iRhythm Technologies Inc
IRTC174.170USD
+5.690+3.38%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
5.61BMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of iRhythm Technologies Inc
Currency: USD Updated: 2025-12-19Key Insights
iRhythm Technologies Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 37/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 220.60.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
iRhythm Technologies Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
16
analysts
Buy
Current Rating
220.600
Target Price
+27.27%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
iRhythm Technologies Inc Highlights
StrengthsRisks
iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry (MCT) monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 44.03% year-on-year.
Undervalued
The company’s latest PE is -108.34, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 36.08M shares, decreasing 12.75% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 3.23M shares of this stock.
Financial Health
Currency: USD Updated: 2025-12-19The current financial score of iRhythm Technologies Inc is 7.08, ranking 103/208 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 192.88M, representing a year-over-year increase of 30.74%, while its net profit experienced a year-over-year increase of 88.71%.
Score
Financials
7.18
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
2.61
Operational Efficiency
9.22
Growth Potential
9.01
Shareholder Returns
7.41
iRhythm Technologies Inc's Company Valuation
Currency: USD Updated: 2025-12-19The current valuation score of iRhythm Technologies Inc is 7.25, ranking 108/208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -108.34, which is -89.15% below the recent high of -11.75 and -8.11% above the recent low of -117.13.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 37/208
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2025-12-19The current earnings forecast score of iRhythm Technologies Inc is 8.63, ranking 25/208 in the Healthcare Equipment & Supplies industry. The average price target for iRhythm Technologies Inc is 220.00, with a high of 244.00 and a low of 194.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
16
analysts
Buy
Current Rating
220.600
Target Price
+27.27%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
90
Total
4
Median
7
Average
Company name
Ratings
Analysts
iRhythm Technologies Inc
IRTC
16
Boston Scientific Corp
BSX
36
Veeva Systems Inc
VEEV
34
Intuitive Surgical Inc
ISRG
34
Edwards Lifesciences Corp
EW
34
Thermo Fisher Scientific Inc
TMO
27
1
2
3
...
18
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-12-19The current price momentum score of iRhythm Technologies Inc is 6.97, ranking 92/208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 188.93 and the support level at 162.95, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
169.386
Buy
MA10
170.419
Buy
MA20
176.778
Sell
MA50
177.409
Sell
MA100
173.943
Buy
MA200
150.175
Buy
Institutional Confidence
Currency: USD Updated: 2025-12-19The current institutional shareholding score of iRhythm Technologies Inc is 10.00, ranking 1/208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 112.00%, representing a quarter-over-quarter decrease of 1.32%. The largest institutional shareholder is The Vanguard, holding a total of 3.23M shares, representing 10.03% of shares outstanding, with 3.28% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
Artisan Partners Limited Partnership
BlackRock Institutional Trust Company, N.A.
Capital Research Global Investors
State Street Investment Management (US)
Geode Capital Management, L.L.C.
William Blair & Company, L.L.C. (Research)
Eventide Asset Management, LLC
Fuller & Thaler Asset Management Inc.
1
2
Risk Assessment
Currency: USD Updated: 2025-12-19The current risk assessment score of iRhythm Technologies Inc is 7.71, ranking 33/208 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.14. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.
Score
Beta vs S&P 500 index
1.14
VaR
+5.36%
240-Day Maximum Drawdown
+18.92%
240-Day Volatility
+50.69%
Return
Best Daily Return
60 days
+4.78%
120 days
+17.68%
5 years
+59.01%
Worst Daily Return
60 days
-5.93%
120 days
-5.93%
5 years
-39.47%
Sharpe Ratio
60 days
+0.16
120 days
+0.82
5 years
+0.39
Risk Assessment
Maximum Drawdown
240 days
+18.92%
3 years
+59.15%
5 years
+71.03%
Return-to-Drawdown Ratio
240 days
+4.69
3 years
+0.34
5 years
+0.07
Skewness
240 days
+2.69
3 years
+1.32
5 years
+2.63
Volatility
Realised Volatility
240 days
+50.69%
5 years
+63.97%
Standardised True Range
240 days
+3.22%
5 years
+3.16%
Downside Risk-Adjusted Return
120 days
+171.85%
240 days
+171.85%
Maximum Daily Upside Volatility
60 days
+36.25%
Maximum Daily Downside Volatility
60 days
+30.91%
Liquidity
Average Turnover Rate
60 days
+1.43%
120 days
+1.47%
5 years
--
Turnover Deviation
20 days
-0.96%
60 days
-0.58%
120 days
+2.24%
Peer Comparison
Healthcare Equipment & Supplies
iRhythm Technologies Inc
IRTC
7.75 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
EW
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LIVN
8.59 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Artivion Inc
AORT
8.59 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
LNTH
8.57 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tactile Systems Technology Inc
TCMD
8.43 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
FAQs
How does TradingKey generate the Stock Score of iRhythm Technologies Inc?
The TradingKey Stock Score provides a comprehensive assessment of iRhythm Technologies Inc based on 34 indicators derived from over 100 underlying data points. These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of iRhythm Technologies Inc’s performance and outlook.
How do we generate the financial health score of iRhythm Technologies Inc?
To generate the financial health score of iRhythm Technologies Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns. By integrating these comprehensive data, the financial health score not only reflects iRhythm Technologies Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of iRhythm Technologies Inc.
How do we generate the company valuation score of iRhythm Technologies Inc?
To generate the company valuation score of iRhythm Technologies Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare iRhythm Technologies Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value. By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of iRhythm Technologies Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of iRhythm Technologies Inc.
How do we generate the earnings forecast score of iRhythm Technologies Inc?
To calculate the earnings forecast score of iRhythm Technologies Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.Comparing these indicators against peers provides context for the stock’s performance and helps
anchor more realistic expectations.These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on iRhythm Technologies Inc’s future.
How do we generate the price momentum score of iRhythm Technologies Inc?
When generating the price momentum score for iRhythm Technologies Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.This comprehensive approach can reflect market sentiment and enable rational forecasts of iRhythm Technologies Inc’s prices. A higher score indicates a more stable short-term price trend for iRhythm Technologies Inc.
How do we generate the institutional confidence score of iRhythm Technologies Inc?
To generate the institutional confidence score of iRhythm Technologies Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about iRhythm Technologies Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of iRhythm Technologies Inc.
How do we generate the risk management score of iRhythm Technologies Inc?
To assess the risk management score of iRhythm Technologies Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.These indicators together provide a multi-dimensional understanding of iRhythm Technologies Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of iRhythm Technologies Inc.
